Executives
-
O'Sullivan MiriamSVP, Chief HR Officer -
Sorenson John BradleyEVP, Global Operations
-
Mirviss Jeffrey B.EVP&Pres, Periph Intervent
-
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
-
Brown Vance RSVP, GC and Corp. Secretary
-
Brennan Daniel J.EVP and CFO
-
Carruthers WendyEVP, Human Resources
-
Woodworth EmilySVP, Global Controller and CAO
-
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, Afr
-
Monson JonathanSVP, Global Controller and CAO
?
Sorenson John Bradley
EVP, Global Operations
Boston Scientific Corporation
US, Marlborough [HQ]
CIK
1629277
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
415,650,000
Price per Share :
$98.66
Equivalence :
$41,008,029,000.00
Transaction History
-
M415,650,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/01/25
-
Footnotes
-
-
Footnotes:#1 On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024.#2 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.#3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.524 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
-
F394,380,000 Shares After TransactionValue : $35,226,021,600.00$1,899,836,400.00Transaction Date : 01/01/25
-
Footnotes
-
-
Footnotes:#1 On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024.#2 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.#3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.524 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
-
S353,190,000 Shares After TransactionValue : $31,794,163,800.00Sold $3,707,923,800.00Transaction Date : 01/02/25
-
Footnotes
-
-
Footnotes:#1 On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024.#2 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.#3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.524 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
-
S329,770,000 Shares After TransactionValue : $29,633,132,200.00Sold $2,104,521,200.00Transaction Date : 01/03/25
-
Footnotes
-
-
Footnotes:#1 On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024.#2 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.#3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.524 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
-
M682,250,000 Shares After TransactionValue : $11,775,635,000.00$3,035,516,200.00Transaction Date : 05/01/24
-
Footnotes
-
-
Footnotes:#1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 6, 2023.#2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $71.201 to $71.83, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.